Sagent Pharma Balance Sheet - Quarterly (NASDAQ:SGNT)

Add to My Stocks
$21.76 $0.03 (0.14%) SGNT stock closing price Aug 29, 2016 (Closing)

A thorough fundamental analysis involves using data from Sagent Pharma balance sheet, apart from other financial statements, to value the business. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Sagent Pharma stock analysis, and provides insights into the firm's financial performance. A company releases its balance sheet every quarter along with its quarterly results. The Sagent Pharma balance sheet for 2016 Q2 shows total assets of $359.01M. The company has a asset turnover ratio of . Also see: Sagent Pharma revenue and Sagent Pharma operating cash flow for the same quarter.

View and download Sagent Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Fiscal year is Jan - Dec2016 Q22016 Q12015 Q4
Cash15.52M12.5M28.96M
Marketable Securities20.16M20.08M20.06M
Receivables50.11M49.88M51.42M
Inventory86.53M83.41M76.45M
Raw Materials12.48M11.61M7.65M
Work In Progress---
Finished Goods83.17M79.05M73.36M
Notes Receivable---
Other Current Assets12.68M11.53M14.69M
Total Current Assets
185.01M177.42M191.59M
Property Plant & Equipment33.3M28.15M23.58M
Accumulated Depreciation4.99M4.49M3.82M
Net Property Plant & Equipment
28.31M23.66M19.76M
Investment & Advances7.85M7.66M7.1M
Other Non-Current Assets---
Deferred Charges52.11M51.75M50.8M
Intangibles84.3M84M78.35M
Deposits & Other Assets1.41M1.45M2.11M
Total Assets
359.01M345.96M349.73M
Notes Payable20.72M--
Accounts Payable48.67M41.79M43.7M
Current Portion Long-Term Debt---
Current Portion Capital Leases---
Accrued Expenses21.16M19.84M23.28M
Income Taxes Payable---
Other Current Liabilities15.99M14.39M16.66M
Total Current Liabilities
85.82M76.02M83.65M
Mortgages---
Deferred Taxes/Income12.05M12.36M12.02M
Convertible Debt---
Long-Term Debt5.97M2.79M1.62M
Non-Current Capital Leases---
Other Long-Term Liabilities1.31M1.33M1.34M
Total Liabilities
105.17M92.51M98.63M
Minority Interest---
Preferred Stock---
Common Stock Net---
Capital Surplus369.22M368.26M367.23M
Retained Earnings-104.49M-103.97M-98.98M
Treasury Stock---
Other Liabilities-11.22M-11.16M-17.48M
Shareholders Equity253.83M253.45M251.09M
Total Liabilities & Shareholders Equity359.01M345.96M349.73M
All figures in USD. M: Millions of USD, B: Billions of USD.

Apart from balance sheet items, an investor would do well to keep track of the Sagent Pharma stock price by looking at Sagent Pharma historical stock prices. One can compare PE with industry average by looking at the Sagent Pharma PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like Sagent Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for SGNT stock as of 2016 Q2 is $359.01M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. SGNT stock had total liabilities of $105.17M for the quarter 2016 Q2.